DEXAMETHASONE-CYCLOPHOSPHAMIDE PULSE THERAPY IN PEMPHIGUS- A CLINICAL STUDY
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2019, Vol 6, Issue 13
Abstract
BACKGROUND Pemphigus is an autoimmune bullous disorder which was life threatening before the advent of steroids and immunosuppressants. Dexamethasone Cyclophosphamide Pulse Therapy introduced by Pasricha and Gupta in 1981 has lifelong recovery from the dreadful disease. We wanted to study the efficacy of DCP with certain modifications in pemphigus group of disorders. METHODS Irrespective of age, sex and severity of disease, 37 patients of pemphigus admitted between 2011 to 2014 who are being treated with DCP and followed for 2-5 years in department of DVL, GGH attached to medical college were included in the study. All patients completed the formalities and were investigated before and after the pulse. DCP regimen was repeated every 28 days with the cycle comprising of 100 mg of Dexamethasone in 500 ml of 5% glucose given intravenously for 3 consecutive days. 500 mg of cyclophosphamide given on Day 1. In between the pulses, 50 mg of oral cyclophosphamide given. Few modifications for better outcome were, additional dose of betamethasone to control disease activity in few severe cases, secondly, use of systemic antibiotics in all cases, anti candidal in cases with oral lesions, thirdly wound care, hygiene, nutritional supplements for fast healing. RESULTS All the patients were in remission. Number of pulses for remission in phase II varied from 11-22. 7 patients required additional 2 mg of oral betamethasone in Phase I. Additional use of mycophenolate mofetil was given in 2 cases with severe recalcitrant mucosal lesions instead of cyclophosphamide. Disease free follow up period was >5 years in 16 pts (45.71%), 3-5 years in 13 pts (37.14%), 2-3 years in 6 pts (17.14%). No deaths occurred in our study. 1 patient was withdrawn from study because of avascular necrosis of femur. Another patient relapsed after 2 years who has taken some native medicine and was found HBsAg positive, was given plain dexamethasone pulse in place of DCP. CONCLUSION Our study clearly established the efficacy of DCP with regard to bringing complete remission and improvement of quality of life. Additional use of betamethasone and MMF in selected cases will further help in complete clearance of lesions.
Authors and Affiliations
Yerrajwala Arunakumari, Panthalla Vijayalakshmi, Indukuri Chandrasekhar Reddy
BILATERAL SIMULTANEOUS ANTERIOR AND POSTERIOR LENTICONUS WITHOUT SYSTEMIC SIGNS
A 21 year male came for eye checkup with a refractive error OD -12.00 sph, - 2.25 @ 160° cyl and OS -15.00 sph, -2.50 @ 5°cyl and was referred to department of refractive surgery for opinion His BCVA in OD 6/18, OS 6/ 24...
A CROSS SECTIONAL ANALYTICAL STUDY OF PSYCHO SOCIAL FACTORS INVOLVED IN THE FIRST ATTEMPT SUICIDE OF YOUNG ADULTS DONE AT THANJAVUR MEDICAL COLLEGE, TAMILNADU
BACKGROUND Attempted Suicide is 8-10 times higher than the number of successful suicides. The suicide risk among persons who attempted suicide is forty times higher than in the general population and the risk persist for...
ADHERENCE TO ANTIRETROVIRAL THERAPY IN A TERTIARY CARE HOSPITAL
BACKGROUND The Million Death Study Collaborators in the British Medical Journal have estimated that the people living with HIV/AIDS population to be between 1.4-1.6 million. Development of Antiretroviral Therapy (ART) ha...
BACTERIOLOGICAL PROFILE AND ANTIBIOTIC SENSITIVITY PATTERN IN ACUTE EXACERBATION OF ADVANCED CASES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Acute exacerbations are significant and frequent events in the natural history of chronic obstructive pulmonary disease. Majority of these exacerbations are of infectious aetiology, bacteria being responsible for 30-50%...
EFFECT OF DOUBLE SURFACE PHOTOTHERAPY ON SERUM MAGNESIUM LEVELS IN TERM AND LATE PRETERM NEONATES
BACKGROUND Hyperbilirubinaemia is one of the most common sign encountered in newborns. Untreated, severe unconjugated hyperbilirubinaemia is potentially neurotoxic. Phototherapy is the first line of treatment in neonatal...